TG Therapeutics, Inc.

NKB2.F·Frankfurt·Healthcare

FollowCompareShare

48.40+1.30 (+2.76%)today

As of Oct 21, 8:02 AM CEST · May be delayed up to 15 min · EUR

1D5D1M6MYTD1Y5Y10Y20YAll

MountainLineCandles

Indicators

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close47.10

Open48.40

Day range—

52-week range23.2251.40

Off day high0.00%

Off 52-week high−5.84%

Volume1.03K

Avg. volume (3M)48.00

Market cap7.41B

EPS (TTM)2.29

Forward P/E-21.14

P/E ratio (TTM)21.14

Dividend yield—

Beta (5Y)1.80

Shares outstanding153.07M

Short interest—

Earnings dateAug 3, 2026

Analyst target—

Profit margin55.22%

Against its peers

Compare in full ›

	NKB2.F	B9A.F	ROIV	VERA	GMAB	9969.HK
Market cap	7.41B	2.35B	27.40B	2.25B	24.33B	20.76B
P/E (TTM)	21.1	240.7	—	—	31.2	19.6
Forward P/E	-21.1	—	-22.1	-7.3	26.1	55.5
Price/book	12.8	1.2	6.5	5.5	4.0	2.3
Dividend yield	—	0.69%	—	—	—	—
1-year change	+57.13%	−2.64%	+103.09%	+10.64%	+32.47%	−8.32%
Today	+2.76%	−0.08%	+3.10%	+3.79%	+1.28%	−6.52%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

Similar businessAlso watched

The businesses closest to NKB2.F's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
B9AFBioArctic AB (publ)B9A.F · Biotechnology	2.35B	26.48	−0.08%
ROIVRoivant Sciences Ltd.ROIV · Biotechnology	27.40B	37.94	+3.10%
VERAVera Therapeutics, Inc.VERA · Biotechnology	2.25B	31.20	+3.79%
GMABGenmab A/SGMAB · Biotechnology	24.33B	39.57	+1.28%
9969InnoCare Pharma Limited9969.HK · Biotechnology	20.76B	11.750	−6.52%
ABCLAbCellera Biologics Inc.ABCL · Biotechnology	3.97B	12.24	+4.53%
LEGNLegend Biotech CorporationLEGN · Biotechnology	3.65B	18.79	+0.86%
BHVNBiohaven Ltd.BHVN · Biotechnology	2.24B	14.84	+26.30%

What visitors to NKB2.F's page also look at.

Company	Mkt cap	Price	Today
DR6FACADIA PHARMACEUTICALS INC.DR6.F	3.04B	17.65	−2.35%
38IFIntellia Therapeutics Inc.38I.F	1.41B	10.08	+0.40%
KK3ACytokinetics Inc.KK3A.F	7.82B	56.22	+2.07%
UP0FUltragenyx Pharmaceutical Inc.RUP0.F	1.38B	13.97	−1.20%
J7ZFJazz Pharmaceuticals PLCJ7Z.F	11.90B	183.30	−2.47%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All NKB2.F news ›

Mugglehead·1d agoNegative

TG Therapeutics reports seven-year BRIUMVI disability and safety findings

Confirmed disability progression affected 11.7 per cent with continuous treatment versus 17.4 per cent after an initial comparator. Confirmed disability progression affected 11.7 per cent of continuously treated BRIUMVI patients over seven…

Stock Titan·1d agoPositive

TG Therapeutics Highlights New Clinical Data Across Multiple Sclerosis Portfolio at MSToronto2026

INVE Technologies Announces the Commencement of a $20 Million Modified Dutch Auction Tender Offer for its Common Stock SCHMID Group Reaches Agreement on Significant Equipment Order to Support HDI Capacity Expansion in Malaysia Nexera…

Stock Titan·Oct 12

TG Therapeutics Announces Publication of Five-Year Comparative Analysis of BRIUMVI Versus Ocrelizumab and Ofatumumab in Relapsing Multiple Sclerosis

BRIUMVI was associated with a lower risk of 24-week confirmed disability progression and lower annualized relapse rates (ARRs) over five years compared with ocrelizumab and ofatumumab The manuscript can be accessed at ScienceDirect.com or…

FinancialContent·Oct 8

Articles from TG Therapeutics, Inc.

FinancialContent Articles from TG Therapeutics, Inc.

Stock Titan·Oct 8

TG Therapeutics Announces Schedule of Data Presentations at MSToronto2026

TG Therapeutics (TGTX) scheduled presentations on azer-cel and BRIUMVI at MSToronto2026, taking place October 21–23, 2026, in Toronto, Canada. Regular abstracts are now available through the MSToronto2026 Online Program, and late-breaking…

From articles in the 4Search news index.

In the news

3mentions in 30 days

3with it in the headline

Positivesentiment

Mentioned with

Pfizer2Abbott Laboratories1Abbvie Inc.1Alnylam Pharmaceuticals1American Academy of Pediatrics1Ascendiant Capital Markets1Ascendiant Capital Markets Raises Igc Pharma Price Target1Astrazeneca1

People in the coverage

Danessa Lincoln2H.c. Wainwright2Marketbeat2Michael Walen2Mitch Edgeman2Sarita Garza2

Themes

All News and Stock Ideas3Biotech and Pharma Stock News3Healthcare3Analyst Recommendations1Cancer1Comparison1Consensus1Dividends1

Most coverage from

1. themarketsdaily.com2
2. financialcontent.com1

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.